NDC 0591-2136-55 - Propofol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-2136
- Requested NDC
- 0591-2136-55
- Package NDCs from labels
- 0591-2136-55, 0591-2136-51, 0591-2136-57, 0591-2136-68, 0591-2136-80, 0591-2136-95
- Manufacturer
- Actavis Pharma, Inc.
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propofol - Actavis Pharma, Inc. | Actavis Pharma, Inc. | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - Henry Schein, Inc. | Henry Schein, Inc. | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol | General Injectables and Vaccines, Inc. | 2018-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-2136-51 | ML - Milliliter | 0591-2136 | 0b14f2f2-28a4-4fb5-a669-08abd4efc03a | 1 | 2016-02-04 |
| 0591-2136-55 | ML - Milliliter | 0591-2136 | c7340b05-171e-42b9-9aaa-f4423b6cba5b | 1 | 2016-02-04 |
| 0591-2136-57 | ML - Milliliter | 0591-2136 | 20f74f85-7313-40e5-a1bd-99d35d50d3cd | 1 | 2016-02-04 |
| 0591-2136-68 | ML - Milliliter | 0591-2136 | 47d8a6dd-b9a7-457a-a1e8-e8e835d9157a | 1 | 2016-02-04 |
| 0591-2136-80 | ML - Milliliter | 0591-2136 | ecc8f542-06b4-4ab8-8638-70de2da9f8bd | 1 | 2016-02-04 |
| 0591-2136-95 | ML - Milliliter | 0591-2136 | 0d8814c1-098b-4f9e-8b00-4e25f3db5dc8 | 1 | 2016-02-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin Laxative | GLYCERIN BASED GENTLE AND EFFECTIVE LAXATIVE ADULT CONSTIPATION RELIEF | NeilMed Pharmaceuticals Inc. | 03b4be69-6488-76be-e063-6394a90a7edf | 2025-01-17 | Warnings | PDC6A3C0OX |
| Beautyturess Collagen Moisturizing Firming 14-Piece Set | BEAUTYTURESS COLLAGEN MOISTURIZING FIRMING 14-PIECE SET | Guangdong Bisutang Biotechnology Co., Ltd. | 2bc94a8a-effb-8319-e063-6394a90a535d | 2025-01-15 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream with Aloe | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Chain Drug Marketing Association | 2b33c710-ac17-20f9-e063-6294a90ad29c | 2025-01-08 | Warnings | PDC6A3C0OX |
| ANTIBACTERIAL DREAMY FLORALS | GLYCERIN | Quimicas Handal de Centroamerica SA de CV | 09f73bec-516d-90f0-e063-6394a90aecab | 2025-01-08 | Warnings | PDC6A3C0OX |
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 99af9e0a-c268-84ca-e053-2a95a90a0a3e | 2025-01-08 | Warnings, Adverse reactions | YI7VU623SF |
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 99c8438a-2b3c-796e-e053-2a95a90a0200 | 2025-01-08 | Warnings, Adverse reactions | YI7VU623SF |
| Prevention Oncology Mouth Rinse | GLYCERIN | Prevention Health Sciences, Inc. | 1ec9ed1c-bcb6-3a0a-e054-00144ff8d46c | 2025-01-01 | Warnings | PDC6A3C0OX |
| CLENZIDERM THERAPEUTIC MOISTURIZER | GLYCERIN | Obagi Cosmeceuticals LLC | d60e22e3-831e-4787-a82c-e7763c287553 | 2025-01-01 | Warnings | PDC6A3C0OX |
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Burts Bees Rapid Rescue Cold Sore Treatment | CAMPHOR, GLYCERIN | Burts Bees | 9f89735d-205f-4d3e-a1e1-ecc96284fe98 | 2024-12-03 | Warnings | PDC6A3C0OX |
| Stratuscare Adult Glycerin | GLYCERIN | Stratus Pharmaceuticals | 3e1935da-5c1f-4942-98dd-320fade82321 | 2024-11-04 | Warnings | PDC6A3C0OX |
| Stratuscare Glycerin Laxative Pediatric | GLYCERIN | Stratus Pharmaceuticals | 6ae6d3c4-bb3b-4436-b76d-8654bf871e66 | 2024-11-01 | Warnings | PDC6A3C0OX |
| Addiclenz | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | 8a3b75ca-8fec-4318-8a55-8bde0b82637d | 2024-10-31 | Warnings | OJ245FE5EU |
| Lipostat | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87309894-d054-4b2f-aeba-bccd25b45f54 | 2024-10-28 | Warnings | 1Z74184RGV |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2024-10-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.